Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes
Authors
Keywords
exenatide, gel, phospholipid, sustained-release, type II diabetes
Journal
PHARMACEUTICAL RESEARCH
Volume 33, Issue 6, Pages 1318-1326
Publisher
Springer Nature
Online
2016-02-09
DOI
10.1007/s11095-016-1873-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides
- (2015) Ting Zhang et al. BIOMATERIALS
- Characterization of the gila monster (Heloderma suspectum suspectum) venom proteome
- (2015) Kristian W. Sanggaard et al. Journal of Proteomics
- A smart insulin patch
- (2015) Omid Veiseh et al. NATURE
- Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification
- (2014) Feng Qi et al. Acta Biomaterialia
- In situ gelling polyvalerolactone-based thermosensitive hydrogel for sustained drug delivery
- (2014) Gyan P. Mishra et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A Novel Doxorubicin-Loaded in Situ Forming Gel Based High Concentration of Phospholipid for Intratumoral Drug Delivery
- (2014) Wenqi Wu et al. MOLECULAR PHARMACEUTICS
- Global diets link environmental sustainability and human health
- (2014) David Tilman et al. NATURE
- Fluorescent Exendin-4 Derivatives for Pancreatic β-Cell Analysis
- (2013) Susan M. Clardy et al. BIOCONJUGATE CHEMISTRY
- Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus
- (2013) Jae Yeon Kim et al. BIOMATERIALS
- A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel
- (2013) Kun Li et al. BIOMATERIALS
- Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability
- (2013) Feng Qi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Injectable implants for the sustained release of protein and peptide drugs
- (2013) Priyanka Agarwal et al. DRUG DISCOVERY TODAY
- Effect of water on exenatide acylation in poly(lactide-co-glycolide) microspheres
- (2013) Rongcai Liang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Once-Weekly Exenatide: An Extended-Duration Glucagon-Like Peptide Agonist for the Treatment of Type 2 Diabetes Mellitus
- (2013) Molly G. Minze et al. PHARMACOTHERAPY
- Pharmacokinetic/pharmacodynamic studies on exenatide in diabetic rats
- (2012) Xin-gang Li et al. ACTA PHARMACOLOGICA SINICA
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- In situ forming implants — an attractive formulation principle for parenteral depot formulations
- (2012) Sabine Kempe et al. JOURNAL OF CONTROLLED RELEASE
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
- (2010) Brian L. Furman TOXICON
- Goals of Treatment for Type 2 Diabetes: -Cell preservation for glycemic control
- (2009) P. Marchetti et al. DIABETES CARE
- Diagnosis and Classification of Diabetes Mellitus
- (2009) DIABETES CARE
- Pharmacokinetics and Efficacy of a Biweekly Dosage Formulation of Exenatide in Zucker Diabetic Fatty (ZDF) Rats
- (2009) Hyun-Hee Kwak et al. PHARMACEUTICAL RESEARCH
- Recent advances and challenges in designing stimuli-responsive polymers
- (2009) Fang Liu et al. PROGRESS IN POLYMER SCIENCE
- Correlation of in vivo and in vitro release data for rh-INFα lipid implants
- (2008) M. Schwab et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus
- (2007) Michael E. Minshall et al. VALUE IN HEALTH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started